Revolution Medicines (RVMDW) Change in Account Payables (2019 - 2026)

Revolution Medicines' Change in Account Payables history runs 8 years deep, the most recent figure standing at $16.9 million for Q1 2026.

• In Q1 2026, Change in Account Payables rose 303.83% year-over-year to $16.9 million; the TTM figure through Mar 2026 stood at $34.7 million (up 143.67% YoY), while the FY2025 annual figure was $9.5 million, up 247.49% from the prior year.
• Change in Account Payables for Q1 2026 stood at $16.9 million, up from -$10.5 million in the prior quarter.
• The five-year high for Change in Account Payables was $29.4 million in Q4 2024, with the low at -$29.0 million in Q1 2024.
• The 5-year median for Change in Account Payables is -$492000.0 (2022), against an average of $3.5 million.
• The sharpest annual moves came in 2022 and 2024: Change in Account Payables soared 5317.46% in 2022, then tumbled 2658.1% in 2024.
• Revolution Medicines' Change in Account Payables stood at -$1.5 million in 2022, then surged by 1712.81% to $24.3 million in 2023, then climbed by 20.81% to $29.4 million in 2024, then slumped by 135.76% to -$10.5 million in 2025, then soared by 260.53% to $16.9 million in 2026.
• Business Quant data shows RVMDW's Change in Account Payables at $16.9 million in Q1 2026, -$10.5 million in Q4 2025, and $19.5 million in Q3 2025.